Systemic vasculitis associated with vemurafenib treatment: Case report and literature review (Q37432850)

20 August 2017

6 references

13 March 2019

17 June 2019

7 November 2019

14 September 2020

25 November 2020

17 December 2020

0 references

Systemic vasculitis associated with vemurafenib treatment: Case report and literature review (English)

1 reference

20 August 2017

1 reference

7 November 2019

1 reference

14 September 2020

1 reference

25 November 2020

1 reference

17 December 2020

8

Patrice Cacoub

1 reference

20 August 2017

Adrien Mirouse

1

1 reference

20 August 2017

Léa Savey

2

1 reference

20 August 2017

Fanny Domont

3

1 reference

20 August 2017

Cloé Comarmond

4

1 reference

20 August 2017

Stéphane Barete

5

1 reference

20 August 2017

Emmanuelle Plaisier

6

1 reference

20 August 2017

Philippe Rouvier

7

1 reference

20 August 2017

David Saadoun

9

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 November 2016

7 references

20 August 2017

13 March 2019

17 June 2019

7 November 2019

14 September 2020

25 November 2020

17 December 2020

7 references

20 August 2017

13 March 2019

17 June 2019

7 November 2019

14 September 2020

25 November 2020

17 December 2020

95

1 reference

20 August 2017

46

1 reference

20 August 2017

e4988

1 reference

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

20 August 2017

6 references

13 March 2019

17 June 2019

7 November 2019

14 September 2020

25 November 2020

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

17 December 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathways

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Panniculitis in patients treated with BRAF inhibitors: a case series

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Vemurafenib-associated neutrophilic panniculitis: An emergent adverse effect of variable severity

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Acute kidney injury in patients with severe rash on vemurafenib treatment for metastatic melanomas.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

BRAF inhibitors-induced panniculitis: a cutaneous side effect mimicking subcutaneous melanoma metastasis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5120889

Vasculitis and panniculitis associated with vemurafenib

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27861332

12 December 2020

inferred from PubMed ID database lookup

Vemurafenib-induced neutrophilic panniculitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27861332

12 December 2020

inferred from PubMed ID database lookup

Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27861332

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1097/MD.0000000000004988

1 reference

release_7rbhbesnlffw5oywoc64vlx35i

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7rbhbesnlffw5oywoc64vlx35i

24 November 2022

mapped directly with Wikidata item

1 reference

20 August 2017

PubMed publication ID

27861332

1 reference